Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?

The tide may be turning when it comes to financing activity in the biotech sector. This week, we saw encouraging signs that investors have an appetite for investment following an industrywide recalibration. In the largest biotech Series C financing so far this year, Generate:Biomedicines raised $273 million and picked up new investors, including Amgen and NVIDIA’s venture capital arm.